Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lice Class Action Lawsuit Discovery To Proceed On All Issues - Calif. Judge

This article was originally published in The Tan Sheet

Executive Summary

Plaintiffs in a proposed California class action against four pediculicide manufacturers will be permitted to seek discovery on the merits of their claims that lice resistance to pesticides has rendered the companies' OTC products ineffective, a San Francisco state court judge ruled Oct. 13.

You may also be interested in...



OTC Permethrin For Lice Still Endorsed Despite Latest Resistance Research

Continued use of permethrin as the front-line treatment for newly diagnosed infestations of head lice is advised by Harvard researchers despite new data showing some lice in the U.S. are resistant to the ingredient. Several OTC lice products, such as Warner-Lambert's Nix, contain permethrin as an active.

LiceGuard Repellant Spray, Shampoo To Reach Stores In September

AAR Health Technologies will introduce two new LiceGuard products, a repellant spray used daily to prevent lice infestations and a lice egg removal shampoo, on store shelves nationwide in September.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS090470

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel